Teceleukin
Teceleukin Uses, Dosage, Side Effects, Food Interaction and all others data.
Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
| Trade Name | Teceleukin |
| Generic | Teceleukin |
| Teceleukin Other Names | Teceleukin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Teceleukin
